Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'alkylating agent' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 131 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Walter, RB; Sung, HM; Obermoeller, RD; Mitchell, DL; Intano, GW; Walter, CA
      Relative base excision repair in Xiphophorus fish tissue extracts

      MARINE BIOTECHNOLOGY
    2. Branda, RF; O'Neill, JP; Brooks, EM; Trombley, LM; Nicklas, JA
      The effect of folate deficiency on the cytotoxic and mutagenic responses to ethyl methanesulfonate in human lymphoblastoid cell lines that differ in p53 status

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    3. Jin, SG; Choi, JH; Ahn, B; O'Connor, TR; Mar, W; Lee, CS
      Excision repair of adozelesin-N3 adenine adduct by 3-methyladenine-DNA glycosylases and UVrABC nuclease

      MOLECULES AND CELLS
    4. Lambert, S; Lopez, BS
      Role of RAD51 in sister-chromatid exchanges in mammalian cells

      ONCOGENE
    5. Vedejs, E; Daugulis, O; Mackay, JA; Rozners, E
      Enantioselective acyl transfer using chiral phosphine catalysts

      SYNLETT
    6. Christodoulou, C; Bafaloukos, D; Kosmidis, P; Samantas, E; Bamias, A; Papakostas, P; Karabelis, A; Bacoyiannis, C; Skarlos, DV
      Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

      ANNALS OF ONCOLOGY
    7. Jansen, M; Bardenheuer, W; Sorg, UR; Seeber, S; Flasshove, M; Moritz, T
      Protection of hematopoietic cells from O-6-alkylation damage by O-6-methylguanine DNA methyltransferase gene transfer: studies with different O-6-alkylating agents and retroviral backbones

      EUROPEAN JOURNAL OF HAEMATOLOGY
    8. van Laar, T; Schouten, T; van der Eb, AJ; Terleth, C
      Induction of the SAPK activator MIG-6 by the alkylating agent methyl methanesulfonate

      MOLECULAR CARCINOGENESIS
    9. Rassnick, KM; Gieger, TL; Williams, LE; Ruslander, DM; Northrup, NC; Kristal, O; Myers, NC; Moore, AS
      Phase I evaluation of CCNU (Lomustine) in tumor-bearing cats

      JOURNAL OF VETERINARY INTERNAL MEDICINE
    10. Shimomura, O; Tomita, I; Endo, T
      Application of novel polymers with S-alkylsulfonium salt moieties as alkylating agents and thermal latent cationic initiators

      JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
    11. Djekou, S; Gellis, A; Maldonado, J; Crozet, MP; Vanelle, P
      A radical synthetic approach to the new potentially bioactive pyrimidinones

      HETEROCYCLES
    12. Blum, T; Ermert, J; Coenen, HH
      Synthesis of asymmetric [Se-75]selenoethers via carbodiimides

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    13. Vassal, G; Tranchand, B; Valteau-Couanet, D; Mahe, C; Couanet, D; Schoeppfer, C; Grill, J; Kalifa, C; Hill, C; Ardiet, C; Hartmann, O
      Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma

      BONE MARROW TRANSPLANTATION
    14. Lakhanpal, S; Donehower, RC; Rowinsky, EK
      Phase II study of 4-ipomeanol, a naturally occurring alkylating furan, in patients with advanced hepatocellular carcinoma

      INVESTIGATIONAL NEW DRUGS
    15. Davies, SM
      Therapy-related leukemia associated with alkylating agents

      MEDICAL AND PEDIATRIC ONCOLOGY
    16. Tsuzuki, T; Egashira, A; Igarashi, H; Iwakuma, T; Nakatsura, Y; Tominaga, Y; Kawate, H; Nakao, K; Nakamura, K; Ide, F; Kura, S; Nakabeppu, Y; Katsuki, M; Ishikawa, T; Sekiguchi, M
      Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    17. Inoue, T; Geyer, RK; Yu, ZK; Maki, CG
      Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents

      FEBS LETTERS
    18. Psaroudi, MC; Kyrtopoulos, SA
      Toxicity, mutation frequency and mutation spectrum induced by dacarbazine in CHO cells expressing different levels of O-6-methylguanine-DNA methyltransferase

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    19. Roth, RB; Samson, LD
      Gene transfer to suppress bone marrow alkylation sensitivity

      MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
    20. Brooks, N; McHugh, PJ; Lee, M; Hartley, JA
      Alteration in the choice of DNA repair pathway with increasing sequence selective DNA alkylation in the minor groove

      CHEMISTRY & BIOLOGY
    21. Inoue, R; Abe, M; Nakabeppu, Y; Sekiguchi, M; Mori, T; Suzuki, T
      Characterization of human polymorphic DNA repair methyltransferase

      PHARMACOGENETICS
    22. Yoshimura, T
      Synthesis and reactions of organic thiazynes

      REVIEWS ON HETEROATOM CHEMISTRY
    23. Watanabe, Y; Haugen-Strano, A; Umar, A; Yamada, K; Hemmi, H; Kikuchi, Y; Takano, S; Shibata, Y; Barrett, JC; Kunkel, TA; Koi, M
      Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer

      MOLECULAR CARCINOGENESIS
    24. Burgess, K; Moore, A; Rand, W; Cotter, SM
      Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide

      JOURNAL OF VETERINARY INTERNAL MEDICINE
    25. Rassnick, KM; Frimberger, AE; Wood, CA; Williams, LE; Cotter, SM; Moore, AS
      Evaluation of ifosfamide for treatment of various canine neoplasms

      JOURNAL OF VETERINARY INTERNAL MEDICINE
    26. Sheehan, D; Meade, G
      Chemical modulation of chemotherapy resistance in cultured oesophageal carcinoma cells

      BIOCHEMICAL SOCIETY TRANSACTIONS
    27. Anderson, FM; O'Hare, CC; Hartley, JA; Robins, DJ
      Synthesis of new homochiral bispyrrolidines as potential DNA cross-linkingantitumour agents

      ANTI-CANCER DRUG DESIGN
    28. Monks, NR; Calvete, JA; Curtin, NJ; Blakey, DC; East, SJ; Newell, DR
      Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)

      BRITISH JOURNAL OF CANCER
    29. Bouffler, SD; Hofland, N; Cox, R; Fodde, R
      Evidence for Msh2 haploinsufficiency in mice revealed by MNU-induced sister-chromatid exchange analysis

      BRITISH JOURNAL OF CANCER
    30. Woynarowski, JM; Napier, C; Trevino, AV; Arnett, B
      Region-specific DNA damage by AT-specific DNA-reactive drugs is predicted by drug binding specificity

      BIOCHEMISTRY
    31. Branda, RF; Lafayette, AR; O'Neill, JP; Nicklaus, JA
      The effect of folate deficiency on the hprt mutational spectrum in Chinesehamster ovary cells treated with monofunctional alkylating agents

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    32. Chen, XM; Cullinane, C; Gray, PJ; Phillips, DR
      DNA damage by nitrogen mustard in a gene containing multiple Sp1-binding sites

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    33. MacNeil, M; Eisenhauer, EA
      High-dose chemotherapy: Is it standard management for any common solid tumor?

      ANNALS OF ONCOLOGY
    34. Rassnick, KM; Moore, AS; Williams, LE; London, CA; Kintzer, PP; Engler, SJ; Cotter, SM
      Treatment of canine mast cell tumors with CCNU (Lomustine)

      JOURNAL OF VETERINARY INTERNAL MEDICINE
    35. Moore, AS; London, CA; Wood, CA; Williams, LE; Cotter, SM; L'Heureux, DA; Frimberger, AE
      Lomustine (CCNU) for the treatment of resistant lymphoma in dogs

      JOURNAL OF VETERINARY INTERNAL MEDICINE
    36. Nieto, Y; Shpall, EJ
      Autologous stem-cell transplantation for solid tumors in adults

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    37. Affar, EB; Shah, RG; Poirier, GG
      Poly(ADP-ribose) turnover in quail myoblast cells: Relation between the polymer level and its catabolism by glycohydrolase

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    38. Hour, TC; Liang, YC; Chu, IS; Lin, JK
      Inhibition of eleven mutagens by various tea extracts, (-)epigallocatechin-3-gallate, gallic acid and caffeine

      FOOD AND CHEMICAL TOXICOLOGY
    39. McClean, S; Costelloe, C; Denny, WA; Searcey, M; Wakelin, LPG
      Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards

      ANTI-CANCER DRUG DESIGN
    40. Horvathova, E; Slamenova, D; Gabelova, A
      Use of single cell gel electrophoresis (comet assay) modifications for analysis of DNA damage

      GENERAL PHYSIOLOGY AND BIOPHYSICS
    41. Qin, XS; Zhou, H; Liu, LL; Gerson, SL
      Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis

      CARCINOGENESIS
    42. Wali, RK; Skarosi, S; Hart, J; Zhang, YC; Dolan, ME; Moschel, RC; Nguyen, L; Mustafi, R; Brasitus, TA; Bissonnette, M
      Inhibition of O-6-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats

      CARCINOGENESIS
    43. Lin, HL; Parsels, LA; Maybaum, J; Hollenberg, PF
      N-nitrosodimethylamine-mediated cytotoxicity in a cell line expressing P450 2E1: Evidence for apoptotic cell death

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    44. Sastre-Coll, A; Esteban, S; Garcia-Sevilla, JA
      Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    45. Sykes, BM; Atwell, GJ; Hogg, A; Wilson, WR; O'Connor, CJ; Denny, WA
      N-substituted 2-(2,6-dinitrophenylamino)propanamides: Novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization

      JOURNAL OF MEDICINAL CHEMISTRY
    46. Atwell, GJ; Milbank, JJB; Wilson, WR; Hogg, A; Denny, WA
      5-amino-1-(chloromethyl)-1,2 dihydro-3H-benz [e]indoles: Relationships between structure and cytotoxicity for analogues bearing different DNA minor groove binding subunits

      JOURNAL OF MEDICINAL CHEMISTRY
    47. Harousseau, JL
      Chemoinduced leukemias

      BULLETIN DU CANCER
    48. Awada, A; Punt, CJA; Piccart, MJ; Van Tellingen, O; Van Manen, L; Kerger, J; Groot, Y; Wanders, J; Verweij, J; Wagener, DJT
      Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule

      BRITISH JOURNAL OF CANCER
    49. Rosati, AM; Traversa, U
      Mechanisms of inhibitory effects of zinc and cadmium ions on agonist binding to adenosine A1 receptors in rat brain

      BIOCHEMICAL PHARMACOLOGY
    50. Eckert, KA; Hile, SE
      Alkylation-induced frameshift mutagenesis during in vitro DNA synthesis byDNA polymerases alpha and beta

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    51. KAINA B
      CRITICAL STEPS IN ALKYLATION-INDUCED ABERRATION FORMATION

      Mutation research. Fundamental and molecular mechanisms of mutagenesis
    52. GLASSNER BJ; POSNICK LM; SAMSON LD
      THE INFLUENCE OF DNA GLYCOSYLASES ON SPONTANEOUS MUTATION

      Mutation research. Fundamental and molecular mechanisms of mutagenesis
    53. KEARNS PR; HALL AG
      GLUTATHIONE AND THE RESPONSE OF MALIGNANT-CELLS TO CHEMOTHERAPY

      Drug discovery today
    54. PICO JL; CASTAGNA L; BOURHIS JH
      RECENT PROGRESS IN THE BIOLOGY OF MULTIPLE-MYELOMA AND FUTURE-DIRECTIONS IN THE TREATMENT

      HEMATOLOGY AND CELL THERAPY
    55. TAKEDA K; SHINOHARA K; KAMEDA N; ARIYOSHI K
      A CASE OF THERAPY-RELATED ACUTE MYELOBLASTIC-LEUKEMIA WITH T(16-21)(Q24-Q22) AFTER CHEMOTHERAPY WITH DNA-TOPOISOMERASE-II INHIBITORS, ETOPOSIDE AND MITOXANTRONE, AND THE ALKYLATING AGENT, CYCLOPHOSPHAMIDE

      International journal of hematology
    56. NOSE K; ISHINO K; SHIBANUMA M
      INCREASE IN TELOMERE SEQUENCE-BINDING ACTIVITY IN NORMAL HUMAN FIBROBLASTS IN SENESCENCE OR IN CELLS TREATED WITH PHORBOL ESTER OR N-METHYL-N'-NITRO-N-NITROSOGUANIDINE

      Biological & pharmaceutical bulletin
    57. BRANDA RF; HACKER M; LAFAYETTE A; NIGELS E; SULLIVAN L; NICKLAS JA; ONEILL JP
      NUTRITIONAL FOLATE-DEFICIENCY AUGMENTS THE IN-VIVO MUTAGENIC AND LYMPHOCYTOTOXIC ACTIVITIES OF ALKYLATING-AGENTS

      Environmental and molecular mutagenesis
    58. Pasquali, S; Maqueo, JD; Vela, J; Kyle, RA; Leong, T; Fritz, E; Suciu, S; Palva, IP; Oivanen, T; Corrado, C; Lastiri, FJ; Peest, D; Kildahl-Andersen, O; Maniatis, A; Alison, R; Clarke, M; Evans, V; Gray, R; Greaves, E; Hall, E; Hicks, C; James, S; Peto, R; Richards, S; Sinclair, D; Tooth, A; Wheatley, K; Avvisati, G; Boccadoro, M; Bugliosi, R; Mandelli, F; Petrucci, MT; Pileri, A; Tribalto, M; Alexanian, R; Delasalle, KB; Child, J; Dunn, J; MacLennan, I; Milligan, D; Mellstedt, H; Osterborg, A; Hjorth, M; Holmberg, E; Rodjer, S; Westin, J; Kamiya, O; Shimizu, K; Bergsagel, DE; Shustik, C; Hippe, E; Kjaersgaard, E; Turesson, I; Westin, J; Riccardi, A; Ucci, G; Blade, J; Fontanillas, M; De Rosa, L; Montuoro, A; Bartolucci, AA; Omura, GA; Stagg, M; Salmon, S; Tangen, C; Jacobs, P; Wood, L; Levy, LM
      Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials

      JOURNAL OF CLINICAL ONCOLOGY
    59. HENDERSON ND; LACY SM; OHARE CC; HARTLEY JA; MCCLEAN S; WAKELIN LPG; KELLAND LR; ROBINS DJ
      SYNTHESIS OF NEW BIFUNCTIONAL COMPOUNDS WHICH SELECTIVELY ALKYLATE GUANINES IN DNA

      Anti-cancer drug design (Print)
    60. Mahmud, NP; Garrett, SW; Threadgill, MD
      The 5-nitrofuran-2-ylmethylidene group as a potential bioreductively activated prodrug system for diol-containing drugs

      ANTI-CANCER DRUG DESIGN
    61. Hugel, B; Weltin, D; Holl, V; Marchal, J; Dufour, P; Freyssinet, JM; Bischoff, PL
      Assessment of apoptosis occurring in spleen cells from nitrogen mustard-treated or gamma-irradiated mice

      ANTICANCER RESEARCH
    62. Denny, WA; Wilson, WR
      The design of selectively-activated anti-cancer prodrugs for use in antibody-directed and gene-directed enzyme-prodrug therapies

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    63. YEGHIAYAN SK; GONGWER MA; BALDESSARINI RJ; KULA NS; ZONG R; NEUMEYER JL
      LOCAL INJECTION OF ALKYLATING AND NONALKYLATING DOPAMINE-RECEPTOR ANTAGONISTS INTO RAT BASAL FOREBRAIN - AUTORADIOGRAPHIC ASSESSMENT OF D-2-LIKE AND D-3 SITES

      Brain research
    64. PUTMAN DL; RITTER AP; CARR GJ; YOUNG RR
      EVALUATION OF SPONTANEOUS AND CHEMICAL-INDUCED LACI MUTATIONS IN GERM-CELLS FROM LAMBDA LACI TRANSGENIC MICE/

      Mutation research. Genetic toxicology and environmental mutagenesis
    65. VANDELFT JHM; BERGMANS A; BAAN RA
      GERM-CELL MUTAGENESIS IN LAMBDA-LACZ TRANSGENIC MICE TREATED WITH ETHYLATING AND METHYLATING AGENTS - COMPARISON WITH SPECIFIC-LOCUS TEST

      Mutation research. Genetic toxicology and environmental mutagenesis
    66. TANAKA T; YOKOMIZO A; UCHIUMI T; FURUKAWA M; WADA M; KUWANO M
      THE CLOSE ASSOCIATION OF PI-CLASS GLUTATHIONE-S-TRANSFERASE WITH DRUG-SENSITIVITY TO ALKYLATING-AGENTS AND CISPLATIN IN HUMAN CANCER-CELLS

      International journal of oncology
    67. BIGIONI M; SALVATORE C; PALMA C; MANZINI S; ANIMATI F; LOMBARDI P; PRATESI G; SUPINO R; ZUNINO F
      CYTOTOXIC AND ANTITUMOR-ACTIVITY OF MEN-10710, A NOVEL ALKYLATING DERIVATIVE OF DISTAMYCIN

      Anti-cancer drugs
    68. SEKIGUCHI M; SAKUMI K
      ROLES OF DNA-REPAIR METHYLTRANSFERASE IN MUTAGENESIS AND CARCINOGENESIS

      Japanese journal of human genetics
    69. KUO ML; CHOU YW; CHAU YP; HUANG TS
      RESISTANCE TO APOPTOSIS INDUCED BY ALKYLATING-AGENTS IN V-HA-RAS-TRANSFORMED CELLS DUE TO DEFECT IN P53 FUNCTION

      Molecular carcinogenesis
    70. OKEN MM
      MULTIPLE-MYELOMA - PROGNOSIS AND STANDARD TREATMENT

      Cancer investigation
    71. VANELLE P; RATHELOT P; MALDONADO J; CROZET MP
      SYNTHESIS OF VARIOUS SUBSTITUTED NITROISOQUINOLINES BY S(RN)1 METHODOLOGY

      Heterocycles
    72. MILLIS KK; LESKO SA; GAMCSIK MP
      FORMATION, INTRACELLULAR-DISTRIBUTION AND EFFLUX OF GLUTATHIONE-BIMANE CONJUGATES IN DRUG-SENSITIVE AND DRUG-RESISTANT MCF-7 CELLS

      Cancer chemotherapy and pharmacology
    73. RAYMOND E; DROLET Y; MARPEAU L; LOUVET C; CADY J; TESSIER C; FAIVRE S; OUELLET P; LAVOIE A; RIOUX E; DEGRAMONT A; KRULIK M
      LONG-TERM FOLLOW-UP AFTER ADJUVANT CHEMOTHERAPY IN COMPLETELY RESECTED EARLY-STAGE OVARIAN-CARCINOMA

      European journal of obstetrics, gynecology, and reproductive biology
    74. SOLBERG Y; ALCALAY M; BELKIN M
      OCULAR INJURY BY MUSTARD GAS

      Survey of ophthalmology
    75. YAMADA M; MATSUI K; SOFUNI T; NOHMI T
      NEW TESTER STRAINS OF SALMONELLA-TYPHIMURIUM LACKING O-6-METHYLGUANINE DNA METHYLTRANSFERASES AND HIGHLY SENSITIVE TO MUTAGENIC ALKYLATING-AGENTS

      Mutation research
    76. LO HW; ALIOSMAN F
      GENOMIC CLONING OF HGSTP1-ASTERISK-C, AN ALLELIC HUMAN PI CLASS GLUTATHIONE-S-TRANSFERASE GENE VARIANT AND FUNCTIONAL-CHARACTERIZATION OF ITS RETINOIC ACID RESPONSE ELEMENTS

      The Journal of biological chemistry
    77. MCHUGH MM; BEERMAN TA; BURHANS WC
      DNA-DAMAGING ENEDIYNE C-1027 INHIBITS INITIATION OF INTRACELLULAR SV40 DNA-REPLICATION IN TRANS

      Biochemistry
    78. LOTZ JP; PENE F; BOULEUC C; ANDRE T; GLIGOROV J; AVENIN D; ESTESO A; BELLAICHE A; MACOVEI C; MERAD Z; LAADEM A; VANICA R; IZRAEL V
      HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STE M-CELL SUPPORT FOR THE TREATMENT OF GYNECOLOGIC TUMORS IN ADULTS

      Contraception fertilite sexualite
    79. ABDAOUI M; DEWYNTER G; AOUF N; MONTERO JL
      SYNTHESIS OF 2-CHLOROETHYLNITROSOSULFAMIDES (CENS) VIA A TRANSSULFAMOYLATION REACTION

      Phosphorus, sulfur and silicon and the related elements
    80. RAMIREZAMADOR V; ESQUIVELPEDRAZA L; MOHAR A; REYNOSOGOMEZ E; VOLKOWFERNANDEZ P; GUARNER J; SANCHEZMEJORADA G
      CHEMOTHERAPY-ASSOCIATED ORAL MUCOSAL LESIONS IN PATIENTS WITH LEUKEMIA OR LYMPHOMA

      European journal of cancer. Part B, Oral oncology
    81. STRUMBERG D; HARSTRICK A; DOLL K; HOFFMANN B; SEEBER S
      BENDAMUSTINE HYDROCHLORIDE ACTIVITY AGAINST DOXORUBICIN-RESISTANT HUMAN BREAST-CARCINOMA CELL-LINES

      Anti-cancer drugs
    82. WAKAZONO Y; KUBOTA M; FURUSHO K; LIU L; GERSON SL
      THYMIDINE KINASE DEFICIENT CELLS WITH DECREASED TTP POOLS ARE HYPERSENSITIVE TO DNA ALKYLATING-AGENTS

      Mutation research. DNA repair
    83. OKUI T; ENDOH D; ARAI S; ISOGAI E; HAYASHI M
      CROSS-SENSITIVITY OF X-RAY-HYPERSENSITIVE CELLS DERIVED FROM LEC STRAIN RATS TO DNA-DAMAGING AGENTS

      Journal of veterinary medical science
    84. KOPFMAIER P; SASS G
      ANTITUMOR-ACTIVITY OF TREOSULFAN IN HUMAN LUNG CARCINOMAS

      Cancer chemotherapy and pharmacology
    85. GOSLAND M; LUM B; SCHIMMELPFENNIG J; BAKER J; DOUKAS M
      INSIGHTS INTO MECHANISMS OF CISPLATIN RESISTANCE AND POTENTIAL FOR ITS CLINICAL REVERSAL

      Pharmacotherapy
    86. MEISENBERG B
      HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL SUPPORT FOR PATIENTS WITH MALIGNANT-MELANOMA

      Bone marrow transplantation
    87. SASSER LB; MILLER RA; KALKWARF DR; CUSHING JA; DACRE JC
      SUBCHRONIC TOXICITY EVALUATION OF SULFUR MUSTARD IN RATS

      Journal of applied toxicology
    88. AHN CM; KIM SK
      SYNTHESIS AND IN-VITRO ANTITUMOR-ACTIVITY OF ISOAZAMITOSENE AND ISOIMINOAZAMITOSENE DERIVATIVES

      Archives of pharmacal research
    89. KLECZKOWSKA HE; ALTHAUS FR
      BIOCHEMICAL-CHANGES ASSOCIATED WITH THE ADAPTIVE RESPONSE OF HUMAN KERATINOCYTES TO N-METHYL-N'-NITRO-N-NITROSOGUANIDINE

      Mutation research. Genetic toxicology testing
    90. KLECZKOWSKA HE; ALTHAUS FR
      RESPONSE OF HUMAN KERATINOCYTES TO EXTREMELY LOW CONCENTRATIONS OF N-METHYL-N'-NITRO-N-NITROSOGUANIDINE

      Mutation research. Genetic toxicology testing
    91. DEWYNTER G; ABDAOUI M; REGAINIA Z; MONTERO JL
      SYNTHESIS OF N-SULFAMOYLOXAZOLIDINONES AND N-PERHYDROOXAZINONES REACTIVITY AND USE AS DONORS IN THE TRANSSULFAMOYLATION REACTION - APPLICATION TO THE PREPARATION OF 2-CHLORETHYLNITROSOSULFAMIDES .4.

      Tetrahedron
    92. TOMICIC M; FRANEKIC J
      EFFECT OF OVEREXPRESSION OF ESCHERICHIA-COLI 3-METHYLADENINE-DNA GLYCOSYLASE-I (TAG) ON SURVIVAL AND MUTATION-INDUCTION IN SALMONELLA-TYPHIMURIUM

      Mutation research
    93. FERGUSON LR; PEARSON AE
      THE CLINICAL USE OF MUTAGENIC ANTICANCER DRUGS

      Mutation research
    94. SANDERSON BJS; SHIELD AJ
      MUTAGENIC DAMAGE TO MAMMALIAN-CELLS BY THERAPEUTIC ALKYLATING-AGENTS

      Mutation research
    95. NIVARD MJM; PASTINK A; VOGEL EW
      MUTATIONAL SPECTRA INDUCED UNDER DISTINCT EXCISION-REPAIR CONDITIONS BY THE 3 METHYLATING AGENTS N-METHYL-N-NITROSOUREA, N-METHYL-N'-NITRO-N-NITROSOGUANIDINE AND N-NITROSODIMETHYLAMINE IN POSTMEIOTIC MALE GERM-CELLS OF DROSOPHILA

      Mutation research
    96. TAKETOMI A; NAKABEPPU Y; IHARA K; HART DJ; FURUICHI M; SEKIGUCHI M
      REQUIREMENT FOR 2 CONSERVED CYSTEINE RESIDUES IN THE ADA PROTEIN OF ESCHERICHIA-COLI FOR TRANSACTIVATION OF THE ADA PROMOTER

      MGG. Molecular & general genetics
    97. PARIKH B; ADVANI S
      PATTERN OF 2ND PRIMARY NEOPLASMS FOLLOWING BREAST-CANCER

      Journal of surgical oncology
    98. DERRICK I; LEWIS JW; MOYNIHAN HA; BROADBEAR J; WOODS JH
      POTENTIAL IRREVERSIBLE LIGANDS FOR OPIOID RECEPTORS - CINNAMOYL DERIVATIVES OF BETA-NALTREXAMINE

      Journal of Pharmacy and Pharmacology
    99. OTVOS F; TOTH G; LOVAS S; SIMON C; HOSZTAFI S
      SYNTHESIS AND TRITIUM LABELING OF 6-BETA-AMINO-4,5-ALPHA-EPOXYMORPHINANS AND THEIR 14-HYDROXY DERIVATIVES AS POTENTIAL AFFINITY LABELING PROBES WITH MU-OPIOID AGONIST ACTIVITY

      Helvetica Chimica Acta
    100. PUNT CJA; HUMBLET Y; ROCA E; DIRIX LY; WAINSTEIN R; POLLI A; CORRADINO I
      TALLIMUSTINE IN ADVANCED PREVIOUSLY UNTREATED COLORECTAL-CANCER, A PHASE-II STUDY

      British Journal of Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 18:41:48